You are using an outdated browser. Please upgrade your browser to improve your experience.
MyHizentra™ Patient App

The MyHizentra™ App has been developed on behalf of CSL Behring (Australia) Pty Ltd ABN 48 160 734 761 (“CSL Behring”), 189–209 Camp Rd, Broadmeadows VIC 3047, Australia

The MyHizentra™ App has been developed on behalf of CSL Behring (Australia) Pty Ltd ABN 48 160 734 761 (“CSL Behring”), 189–209 Camp Rd, Broadmeadows VIC 3047, Australia

MyHizentra™ Patient App

by CSL Behring LLC
MyHizentra™ Patient App
MyHizentra™ Patient App

What is it about?

The MyHizentra™ App has been developed on behalf of CSL Behring (Australia) Pty Ltd ABN 48 160 734 761 (“CSL Behring”), 189–209 Camp Rd, Broadmeadows VIC 3047, Australia.

MyHizentra™ Patient App

App Details

Version
1.1
Rating
NA
Size
28Mb
Genre
Medical
Last updated
February 4, 2017
Release date
September 8, 2016
More info

App Store Description

The MyHizentra™ App has been developed on behalf of CSL Behring (Australia) Pty Ltd ABN 48 160 734 761 (“CSL Behring”), 189–209 Camp Rd, Broadmeadows VIC 3047, Australia.

This app is designed to be used only by Australian patients prescribed HIZENTRA®. An activation code is therefore required to access the app. Australian patients can contact their nurse or doctor to request an activation code. The app includes information about HIZENTRA® and a patient diary to record HIZENTRA® infusions, which includes barcode scanning/decoding and functionality to send a tabulated form of the diary to a patients nurse or doctor. Also provided is an infusion reminder service and functionality for a patient to record and manage their HIZENTRA® stock in the home.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to [email protected] and your information will be removed.